Study designs of evaluations included in the review
Prospective studies with 20 patients enrolled, which reported the total number of patients treated and who underwent angiography.
Specific interventions included in the review
Intravenous thrombolysis with accelerated and standard-dose tissue-plasminogen activator (TPA), anisoylated plasminogen streptokinase activator complex (APSAC) and streptokinase.
Participants included in the review
Patients with acute MI and ST-segment elevation (patient criteria are not stated clearly).
Outcomes assessed in the review
Thrombolysis in MI (TIMI) grade 3 flow and reocclusion rates, defined as angiographically-documented occlusion of an infarct-artery that had been patent at a 90-minute angiogram.
How were decisions on the relevance of primary studies made?
The authors do not state how the papers were selected for the review, apart from that the studies had to meet predefined selection criteria, or how many of the authors perfomed the selection.